Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
System protects oral solid drug products with a 3-Phase Activ-Polymer solution, including moisture adsorption, oxygen and odor scavenging.
October 24, 2019
By: Kristin Brooks
Managing Editor, Contract Pharma
AptarGroup’s Activ-Blister packaging solution for oral solid dose drug delivery was recently approved by the U.S. Food and Drug Administration (FDA) for a HIV prevention medicine. The oral solid dose drug was developed by a leading pharmaceutical company in the HIV treatment and prevention space, and represents the first FDA approval of Aptar’s Activ-Blister packaging solution and application process developed by Aptar CSP Technologies. The system protects oral solid drug products with a 3-Phase Activ-Polymer solution that is fully integrated into the blister package. This technology can be customized specifically for the drug developer’s formulation and offers a broad spectrum of specific drug protection including moisture adsorption, and oxygen and odor scavenging. The technology can also scavenge volatile organic compounds (VOCs) and emit aromas. Aptar’s portfolio of 3-Phase Activ-Polymerprotective solutions helps pharma and biopharma partners meet specific drug long-term and in-use stability requirements while maintaining therapeutic efficacy, as well as a patient-friendly packaging configuration. “I am very pleased to announce this recent FDA approval of our proprietary Activ-Blister technology,” said Stephan Tanda, Aptar’s president and chief executive officer. “This is a significant step that further validates the expanding portfolio of solutions offered by Aptar CSP Technologies. We will continue to leverage our proprietary 3-Phase Activ-Polymertechnology to help our customers with unique protective formulations that derisk their drug development process and help strengthen their own offerings. The ultimate result is that we are creating meaningful solutions that help improve and save lives.” Visit Aptar at CPhI booth 111D70.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !